
Outset Medical OM
$ 4.2
2.44%
Annual report 2025
added 02-13-2026
Outset Medical Accounts Payables 2011-2026 | OM
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Outset Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 554 K | 3.86 M | 5.83 M | 603 K | 1.76 M | 4.95 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.83 M | 554 K | 2.93 M |
Quarterly Accounts Payables Outset Medical
| 2025-Q3 | 2024-Q4 | 2024-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.72 M | 3.86 M | - | - | - | - | 5.15 M | 1.76 M | 2.7 M | 2.36 M | 6.65 M | 4.95 M | 4.95 M | 4.95 M | 4.95 M | 4.96 M | 4.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.65 M | 1.72 M | 4.15 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
109 M | $ 176.83 | 5.97 % | $ 13.2 B | ||
|
Alphatec Holdings
ATEC
|
40.9 M | $ 11.66 | 5.71 % | $ 1.75 B | ||
|
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | ||
|
Acutus Medical
AFIB
|
2.76 M | - | -26.83 % | $ 2.62 M | ||
|
AxoGen
AXGN
|
2.89 M | $ 34.0 | 9.71 % | $ 1.57 B | ||
|
AdaptHealth Corp.
AHCO
|
352 M | $ 12.18 | 2.01 % | $ 1.65 B | ||
|
Cardiovascular Systems
CSII
|
14.4 M | - | 0.15 % | $ 844 M | ||
|
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | ||
|
Dynatronics Corporation
DYNT
|
3.4 M | - | 14.99 % | $ 929 K | ||
|
Bio-Rad Laboratories
BIO
|
122 M | $ 281.15 | 1.13 % | $ 7.93 B | ||
|
Second Sight Medical Products
EYES
|
1.03 M | - | -0.97 % | $ 54.4 M | ||
|
Bruker Corporation
BRKR
|
234 M | $ 38.25 | 4.31 % | $ 5.7 K | ||
|
GBS
GBS
|
1.47 M | - | -0.57 % | $ 7.12 M | ||
|
Boston Scientific Corporation
BSX
|
1.14 B | $ 62.56 | 1.15 % | $ 92.6 B | ||
|
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | ||
|
Electromed
ELMD
|
2.67 M | $ 24.4 | 2.61 % | $ 206 M | ||
|
ClearPoint Neuro
CLPT
|
1.26 M | $ 9.17 | 1.1 % | $ 260 M | ||
|
Globus Medical
GMED
|
98.9 M | $ 91.96 | 2.13 % | $ 12.4 B | ||
|
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | ||
|
Invacare Corporation
IVC
|
105 M | - | - | $ 24.7 M | ||
|
Axonics Modulation Technologies
AXNX
|
9.07 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | ||
|
Butterfly Network
BFLY
|
4.25 M | $ 4.14 | 2.22 % | $ 876 M | ||
|
Nevro Corp.
NVRO
|
24.5 M | - | - | $ 217 M | ||
|
Cytosorbents Corporation
CTSO
|
2.87 M | $ 0.62 | 1.67 % | $ 38.6 M | ||
|
EDAP TMS S.A.
EDAP
|
5.71 M | $ 3.37 | -0.88 % | $ 126 M | ||
|
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
2.66 M | $ 9.85 | 1.86 % | $ 353 M | ||
|
CONMED Corporation
CNMD
|
93.6 M | $ 36.59 | 5.94 % | $ 1.14 B | ||
|
FONAR Corporation
FONR
|
1.55 M | $ 18.62 | 0.22 % | $ 122 M | ||
|
Edwards Lifesciences Corporation
EW
|
228 M | $ 81.71 | 1.08 % | $ 47.8 B | ||
|
Inspire Medical Systems
INSP
|
36.6 M | $ 53.38 | -1.89 % | $ 1.57 B | ||
|
Varex Imaging Corporation
VREX
|
69.9 M | $ 11.04 | 4.25 % | $ 457 M | ||
|
Helius Medical Technologies
HSDT
|
531 K | $ 1.88 | 2.73 % | $ 1.14 M | ||
|
Inogen
INGN
|
20.3 M | $ 6.67 | -1.91 % | $ 177 M | ||
|
IRIDEX Corporation
IRIX
|
5.38 M | $ 1.03 | - | $ 17.4 M | ||
|
Integer Holdings Corporation
ITGR
|
113 M | $ 87.48 | 2.78 % | $ 3.04 B | ||
|
OrthoPediatrics Corp.
KIDS
|
18.8 M | $ 16.01 | 1.59 % | $ 376 M |